Intensity Therapeutics is a cutting-edge biotechnology company based in Norwalk, CT, that is revolutionizing cancer treatment. Their innovative intratumoral delivery technology allows for the creation of drug products that not only kill cancer cells but also activate a systemic immune response, enabling immune cells to attack tumors throughout the body. With a mission to extend the lives of patients with metastatic cancer and prevent disease recurrence, Intensity Therapeutics is at the forefront of the war against cancer.
At Intensity Therapeutics, their proprietary penetration enhancer platform technology, DfuseRx, enables therapeutic agents to be injected directly into solid tumors, improving absorption and increasing the drug's diffusion into cancer cells. This localized cell death induces an influx of immune cells throughout the tumor, leading to a system-wide immune response. With promising clinical results and a focus on personalized treatment, Intensity Therapeutics is dedicated to increasing survival rates and improving the quality of life for cancer patients.
Generated from the website